HPS Pharmacies wish to give notice that Baxter Healthcare is experiencing a supply interruption for Cernevit® as follows:
This global supply interruption is due to a combination of increased demand, manufacturing capacity constraints, and international transport issues. Baxter will be monitoring all Cernevit® orders over the coming weeks and taking action to minimise any disruption. However, it is anticipated that some orders may be delayed.
Normal supplies of Cernevit® are expected to resume by end-September 2021.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Baxter Healthcare on 1800 229 837 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates